These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19822232)

  • 1. Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.
    Balogun HA; Vasconcelos NM; Lindberg R; Haeggström M; Moll K; Chen Q; Wahlgren M; Berzins K
    Vaccine; 2009 Dec; 28(1):90-7. PubMed ID: 19822232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pf332-C231-reactive antibodies affect growth and development of intra-erythrocytic Plasmodium falciparum parasites.
    Balogun HA; Awah NW; Farouk SE; Berzins K
    Vaccine; 2011 Dec; 30(1):21-8. PubMed ID: 22064263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh.
    Giha HA; Nasr A; Iriemenam NC; Balogun HA; Arnot D; Theander TG; Troye-Blomberg M; Berzins K; ElGhazali G
    Vaccine; 2010 Feb; 28(7):1732-9. PubMed ID: 20036751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332.
    Iqbal J; Perlmann P; Berzins K
    Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.
    Israelsson E; Balogun H; Vasconcelos NM; Beser J; Roussilhon C; Rogier C; Trape JF; Berzins K
    Clin Exp Immunol; 2008 Apr; 152(1):64-71. PubMed ID: 18279441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.
    Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K
    Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2.
    Felger I; Steiger S; Hatz C; Smith T; Beck HP
    Parasite Immunol; 2003; 25(11-12):531-43. PubMed ID: 15053774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.
    Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K
    Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of antibodies to the Duffy binding like domain of Plasmodium falciparum antigen Pf332 in Senegalese individuals.
    Balogun HA; Awah N; Nilsson S; Rogier C; Trape JF; Chen Q; Roussilhon C; Berzins K
    Acta Trop; 2014 Feb; 130():80-7. PubMed ID: 24200839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against recombinant histidine-rich protein 2 of Plasmodium falciparum and their use in malaria diagnosis.
    Merwyn S; Gopalan N; Singh AK; Rai GP; Agarwal GS
    Hybridoma (Larchmt); 2011 Dec; 30(6):519-24. PubMed ID: 22149276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses to the Plasmodium falciparum antigen Pf155 RESA in adults with differential clinical conditions from an Indian zone where malaria is endemic.
    Biswas S; Rao DN; Roy A; Yadav RP; Ghosh SK; Kabilan L
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):219-27. PubMed ID: 8629049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
    Iqbal J; Rab A; Perlmann P; Berzins K
    Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
    Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
    J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria.
    Dodoo D; Theisen M; Kurtzhals JA; Akanmori BD; Koram KA; Jepsen S; Nkrumah FK; Theander TG; Hviid L
    J Infect Dis; 2000 Mar; 181(3):1202-5. PubMed ID: 10720556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective antibody response to recombinant fragments of Plasmodium falciparum apical membrane antigen 1].
    Li X; Xue CF; Liu ZX; Wang XF; Ding J; Lei JC; Zhen RF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(2):80-3. PubMed ID: 12884614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.